Pnc Financial Services Group, Inc. Kymera Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 13 shares of KYMR stock, worth $526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$526
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KYMR
# of Institutions
183Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$269 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$243 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$209 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$198 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$193 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.22B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...